STBT5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 453: | Line 453: | ||
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]] | |[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]] | ||
|Disease | |Disease | ||
| | |Kati | ||
e Schieffer | |||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/12/2025 | ||
| | |Katie Schieffer | ||
| | |12/12/2025 | ||
| | |Minimal genetic content added | ||
|- | |- | ||
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]] | |[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]] | ||
| Line 521: | Line 522: | ||
|9/24/2025 | |9/24/2025 | ||
|12/24/2025 | |12/24/2025 | ||
| | |COMPLETE | ||
| | |12/18/2025 | ||
| | |Katie Schieffer | ||
| | |12/18/2025 | ||
| | | | ||
|- | |- | ||
| Line 562: | Line 563: | ||
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]] | |[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]] | ||
|Disease | |Disease | ||
| | |Mokhtar Abdelhammed, MD (trainee); | ||
| | Katie Schieffer (mentor) | ||
| | |3/1/2026 | ||
| | |6/30/2026 | ||
|PENDING | |||
| | | | ||
| | | | ||
| Line 792: | Line 794: | ||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/11/2025 | ||
| | |Katie Schieffer | ||
| | |12/11/2025 | ||
| | |Minimal genetic content added | ||
|- | |- | ||
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]] | |[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]] | ||
| Line 911: | Line 913: | ||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/12/2025 | ||
| | |Katie Schieffer | ||
| | |12/12/2025 | ||
| | |No genetic association | ||
|- | |- | ||
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]] | |[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]] | ||
| Line 1,096: | Line 1,098: | ||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/11/2025 | ||
| | |Katie Schieffer | ||
| | |12/11/2025 | ||
| | |No genetic association | ||
|- | |- | ||
|- | |- | ||
| Line 1,116: | Line 1,118: | ||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/11/2025 | ||
| | |Katie Schieffer | ||
| | |12/11/2025 | ||
| | |No genetic association | ||
|- | |- | ||
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | |[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]] | ||
| Line 1,131: | Line 1,133: | ||
| | | | ||
| | | | ||
| | |Consider linking to CNS tumor book | ||
|- | |- | ||
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]] | |[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]] | ||
| Line 1,193: | Line 1,195: | ||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/12/2025 | ||
| | |Katie Schieffer | ||
| | |12/12/2025 | ||
| | |No genetic association | ||
|- | |- | ||
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]] | |[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]] | ||
| Line 1,269: | Line 1,271: | ||
|9/11/2025 | |9/11/2025 | ||
|12/11/2025 | |12/11/2025 | ||
| | |COMPLETE | ||
| | |12/29/2026 | ||
|Katie Schieffer | |Katie Schieffer | ||
| | |1/7/2026 | ||
| | | | ||
|- | |- | ||
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]] | |[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]] | ||
|Disease | |Disease | ||
| | |Mokhtar Abdelhammed, MD (trainee); | ||
| | Katie Schieffer (mentor) | ||
| | |3/1/2026 | ||
| | |6/30/2026 | ||
|PENDING | |||
| | | | ||
| | | | ||
| Line 1,335: | Line 1,338: | ||
|10/13/2025 | |10/13/2025 | ||
|12/31/2025 | |12/31/2025 | ||
| | |COMPLETE | ||
| | |12/24/2025 | ||
|Katie Schieffer | |Katie Schieffer | ||
| | |12/24/2025 | ||
| | | | ||
|- | |- | ||
| Line 1,374: | Line 1,377: | ||
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | |[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | ||
|Disease | |Disease | ||
| | |Maxine Sutcliffe, PhD | ||
| | |1/12/2026 | ||
| | |4/12/2026 | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,510: | Line 1,513: | ||
---- | ---- | ||
| | | | ||
---- | ---- | ||
| | | | ||
---- | ---- | ||
| | | | ||
---- | ---- | ||
| | | | ||
---- | ---- | ||
| | | | ||
---- | ---- | ||
| | | | ||
---- | ---- | ||
|- | |- | ||
|[[STBT5:Subungual_exostosis|Subungual exostosis]] | |[[STBT5:Subungual_exostosis|Subungual exostosis]] | ||
|Disease | |Disease | ||
|Katie Schieffer | |Katie Schieffer | ||
|9/21/2025 | |9/21/2025 | ||
|12/21/2025 | |12/21/2025 | ||
| | |COMPLETE | ||
| | |12/12/2025 | ||
| | |Katie Schieffer | ||
| | |12/12/2025 | ||
| | |No genetic association | ||
|- | |- | ||
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]] | |[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]] | ||
| Line 2,062: | Line 2,065: | ||
| | | | ||
| | | | ||
| | |Refer to lipoma and hibernoma pages in STBT book | ||
|- | |- | ||
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]] | |[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]] | ||
| Line 2,073: | Line 2,076: | ||
| | | | ||
| | | | ||
| | |Refer to leiomyosarcoma page in STBT book | ||
|- | |- | ||
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]] | |[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]] | ||
| Line 2,117: | Line 2,120: | ||
| | | | ||
| | | | ||
| | |Refer to heme book | ||
|- | |- | ||
|- | |- | ||
| Line 2,137: | Line 2,140: | ||
| | | | ||
| | | | ||
| | |Refer to heme book | ||
|- | |- | ||
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]] | |[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]] | ||
| Line 2,148: | Line 2,151: | ||
| | | | ||
| | | | ||
| | |Refer to heme book | ||
|- | |- | ||
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | |[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]] | ||
| Line 2,159: | Line 2,162: | ||
| | | | ||
| | | | ||
| | |Refer to heme book | ||
|- | |- | ||
| | | | ||